BACKGROUND Some studies have revealed an improvement in glucose metabolism after proton-pump inhibitors (PPI) therapy; however, this evidence is inconclusive and limited. OBJECTIVE To examine the effect of PPI on… Click to show full abstract
BACKGROUND Some studies have revealed an improvement in glucose metabolism after proton-pump inhibitors (PPI) therapy; however, this evidence is inconclusive and limited. OBJECTIVE To examine the effect of PPI on glucose and insulin metabolism in patients with type 2 diabetes through a systematic review and metaanalysis. METHODS Only randomized controlled trials evaluating the impact of PPI on glucose or insulin concentrations in type 2 diabetes were searched in PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases. Meta-analysis was conducted using a random-effects model and generic inverse variance method. Sensitivity analysis was performed using leave one-out method. RESULTS Meta-analysis revealed no significant effect of PPI intervention on fasting glucose (mean difference [MD] -11.42 [95% CI, -29.68 to 6.83, p = 0.22], I 2 = 80%, p = 0.22), fasting insulin (MD 1.51 [95% CI, -0.36 to 3.37], I 2 = 32%, p = 0.11), HOMA-IR (MD -0.16 [-0.98 to 0.65], I 2 = 0%, p = 0.70), HOMA-β (MD 19.97 [-21.59 to 61.52], I 2 = 71%, p = 0.35), and HbA1c concentrations (MD -0.34 [-0.99 to 0.31], I 2 = 89%, p = 0.30). CONCLUSION The treatment with PPI, in the short term, had not significant effect on glucose and insulin metabolism in patients with type 2 diabetes.
               
Click one of the above tabs to view related content.